Forward Pharma A/S
FWPAY · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $1 | $3 |
| G&A Expenses | $4 | $3 | $4 | $10 |
| SG&A Expenses | $4 | $3 | $4 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $3 | $5 | $12 |
| Operating Income | -$4 | -$3 | -$5 | -$12 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | -$3 | $1 | $3 |
| Pre-Tax Income | -$2 | -$6 | -$4 | -$9 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$2 | -$6 | -$4 | -$9 |
| % Margin | – | – | – | – |
| EPS | -77.41 | -268.72 | -177.58 | -368.51 |
| % Growth | 71.2% | -51.3% | 51.8% | – |
| EPS Diluted | -77.41 | -268.72 | -177.58 | -368.51 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$2 | $3 | $0 | $0 |
| EBITDA | -$6 | -$0 | -$6 | -$15 |
| % Margin | – | – | – | – |